ResMed, Inc. (RMD)
252.31
-3.04
(-1.19%)
USD |
NYSE |
Jan 23, 16:00
252.31
0.00 (0.00%)
After-Hours: 16:08
ResMed Research and Development Expense (TTM): 339.08M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 1.943B |
| Abbott Laboratories | 2.89B |
| Stryker Corp. | 1.529B |
| West Pharmaceutical Services, Inc. | 71.00M |
| Insulet Corp. | 270.80M |